Article
Cytoskeletal gene alterations linked to sorafenib resistance in hepatocellular carcinoma
2024-03-05
Abstract excerpt
<h4>Background: </h4> Although sorafenib has been consistently used as a first-line treatment for advanced hepatocellular carcinoma (HCC), most patients will develop resistance, and the mechanism of resistance to sorafenib needs further study. Methods Using KAS-seq technology, we obtained the ssDNA profiles within the whole genome range of 7721 cells treated with sorafenib for differential analysis. We then inter...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ca7c9ca9-b127-5c0f-8199-26cc0bd610da
- DOI
- 10.21203/rs.3.rs-3996234/v1
